• Nie Znaleziono Wyników

Seymour Furman, MD (1931–2006)

N/A
N/A
Protected

Academic year: 2022

Share "Seymour Furman, MD (1931–2006)"

Copied!
2
0
0

Pełen tekst

(1)

351 www.fc.viamedica.pl

OBITUARY

Folia Cardiol.

2006, Vol. 13, No. 4, pp. 351–352 Copyright © 2006 Via Medica ISSN 1507–4145

Dear Colleagues,

Recently, we lost Dr. Seymour Furman — a giant of cardiology, and also a friend and member of Editorial Board of Folia Cardiologica. We are grateful to Dr. Serge Barold for writing special obituary note on Dr. Furman.

Wojciech Zaręba

Seymour Furman, MD (1931–2006)

Seymour Furman, an internationally recognized pioneer and expert on pace- makers and cardiac electrophysiology, died on February 20 2006. Furman atten- ded the State University of New York (SUNY) Downstate College of Medicine and was an intern and a resident in gene- ral surgery at Montefiore Hospital in the Bronx, New York. During 1962–1963 he was a thoracic surgical resident at the

Baylor University affiliated hospitals in Houston, Texas. He then returned to Montefiore Hospital as a staff cardiac surgeon and thereafter spent his en- tire academic career there, and at Albert Einstein College of Medicine, where he eventually became Professor of Medicine and Surgery.

On July 16 1958 at Montefiore Hospital, Fur- man created history by successfully pacing the ri- ght ventricle in man with a transvenous electrode catheter [1]. The lead was introduced with fluoro- scopy, via the median basilic vein in a patient with complete atrioventricular block who required colon resection because of a malignancy. The pacemaker was powered by ordinary line alternating current and the electrode system consisted of a solid cop- per wire with a bare terminal tip and a skin wire to complete the circuit. Pacing was performed for two hours during the operative procedure, and ended with the return of the previous idioventricular rhy- thm upon removal of the catheter. The second pa- tient was paced successfully from the right ventricle for three months during his hospital stay (via the basilic vein despite lead instability) and remarka- bly, became ambulatory by pushing a cart with a large pacemaker that had to be repeatedly

connected by long electric cords to elec- trical outlets in the various corridors of the hospital. The 1959 published report of transvenous ventricular pacing in the first three patients [1], is generally considered the beginning of clinical cardiac electro- physiology.

Dr Furman remained a world leader in pacing and electrophysiology for al- most 50 years. He trained many physi- cians who went on to establish their own centers of excellence all over the world. His numerous contributions include the development of portable pacemakers, establishment of factors controlling electrode efficiency by utilizing the strength-du- ration curve, increasing battery longevity by redu- cing current drain, and the importance of recor- ding endocardial electrograms. Furman also deve- loped the concept of organized device follow-up in a pacemaker clinic and transtelephonic monitoring.

In 1970 Furman and Escher coauthored the first American book on cardiac pacing, ”Principles and Techniques of Cardiac Pacing” and in 1989 he was the principal author of ”A Practice of Cardiac Pacing” a book that dominated the field for many years with three successive editions. Over his pro- lific career, Dr. Furman published over 400 manu- scripts and book chapters, 100 editorials in Pacing and Cardiac Electrophysiology (PACE), 800 abs- tracts, and gave more than 1,000 oral presentations all over the world.

Dr Furman co-founded the North American Society of Pacing and Electrophysiology (NASPE) now called the Heart Rhythm Society (HRS) and remained an active member of the Society until his

(2)

352

Folia Cardiol. 2006, Vol. 13, No. 4

www.fc.viamedica.pl

death. He founded the journal Pacing and Clinical Electrophysiology (PACE) in 1977 and remained its editor for over 25 years. Furman also established an examination process (NASPEeXAM) to mainta- in high intellectual standards in cardiac pacing and defibrillation.

Furman was a legend of his time with many friends and admirers and was the recipient of many awards from prestigious learned societies. Every-

S. Serge Barold, MD Division of Cardiology, University of South Florida College of Medicine and Tampa General Hospital 5806 Mariner’s Watch Drive, Tampa, Florida 33615, USA Fax: 813 891 1908, e-mail ssbarold@aol.com body involved in pacing and electrophysiology will miss Seymour Furman for his leadership, wisdom, honesty, friendship, and humanity.

Reference

1. Furman S, Schwedel JB. An intracardiac pacemaker for Stokes-Adams seizures. N Engl J Med, 1959; 261:

943–948.

Cytaty

Powiązane dokumenty

Comorbidities (or medical interventions) leading to an increased risk of infective endocarditis This recommendation applies to patients undergoing dial- ysis or other

pothesis that CM resection provides very good short‑ and long ‑term postoperative outcomes and remains the treatment of choice in patients with this rare cardiac

Furman uczęszczał na uniwer- sytet stanowy w Nowym Jorku (SUNY, State University of New York) do Down- state College of Medicine, gdzie był inter- nistą i rezydentem chirurgii ogólnej

Conclusion: oversensing of the T wave in car- riers of a cardiac resynchronization therapy device can provoke a low percentage of ventricular pacing and therefore a failure in

Serum brain natriuretic peptide (BNP) level during clinical course and duration of admission, occurrence of paroxysmal atrial fibrillation (AF), atrial tachycardias (AT) and NYHA

Atrial (AAIR) and dual-chamber (DDDR) per- manent cardiac pacing in patients with sick sinus syndrome and preserved left ventricular systolic function did not provoke any

Evalu- ation of the influence of various shapes of the pacing pulse on the ventricular excitation threshold, the electric energy transmitted to the system of electrodes and the

Administration of human recombinant activated protein C significantly reduces multiple organ dysfunction during the course of septic shock and enables further effective therapy to